Demo Sign up Log In

Lineage Cell Therapeutics, Inc. Common Stock (LCTX)

Operating Expenses

$39.49M

TTM · Period ending: Jun 30, 2026 · USD

LCTX Operating Expenses

Latest reported$39.49Mperiod endingJun 30, 2026

Latest reported$39.49Mperiod endingJun 30, 2026

LCTX TTM Operating Expenses ($700.00K → $39.49M)

TTM operating expenses

High-resolution chart · PNG

LCTX operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Lineage Cell Therapeutics, Inc. Common Stock Operating Expenses — Trailing twelve months (TTM) (USD)
Period ending	Operating Expenses (USD)
Jun 30, 2001	4,563,462
Mar 31, 2001	4,805,467
Dec 31, 2000	5,218,230
Sep 30, 2000	5,662,828
Jun 30, 2000	6,757,792
Mar 31, 2000	7,060,403
Dec 31, 1999	6,856,751
Sep 30, 1999	6,600,000
Jun 30, 1999	5,300,000
Mar 31, 1999	4,900,000
Sep 30, 1998	5,000,000
Jun 30, 1998	4,900,000
Mar 31, 1998	5,000,000
Dec 31, 1997	4,300,000
Sep 30, 1997	3,800,000
Jun 30, 1997	3,300,000
Mar 31, 1997	0
Dec 31, 1996	-600,000
Sep 30, 1996	-1,400,000
Jun 30, 1996	-1,800,000
Mar 31, 1996	1,100,000
Dec 31, 1995	1,700,000
Sep 30, 1995	2,400,000
Jun 30, 1995	2,600,000
Mar 31, 1995	2,400,000
Dec 31, 1994	2,100,000
Sep 30, 1994	1,600,000
Jun 30, 1994	1,300,000
Mar 31, 1994	900,000
Dec 31, 1993	800,000
Sep 30, 1993	800,000
Jun 30, 1993	800,000
Mar 31, 1993	800,000
Dec 31, 1992	700,000

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.